SIAM CHOWDHURY

Scroll down ⬇️

Presented research in American Chemical Society (ACS) - Fall 2025 Conference on August 17 to 21, at Walter E. Washington Convention Center, in Washington, D.C. It was 6th number of conference attended by SIAM CHOWDHURY.

INBRE Sponsored Bench to Bedside Breakthroughs in Cancer Research and Therapy Workshop on MAY 28, 2025, at University of Arkansas for Medical Sciences ( UAMS Winthrop P. Rockefeller Cancer Institute ) Little Rock, Arkansas.

Attending the workshop, March 20, 2025 FUNDAMENTALS OF PROTEOMICS FOR FACULTY & STUDENTS at UAMS Winthrop P. Rockefeller Cancer Institute, Little Rock, Arkansas.

Chowdhury published his first research paper as a Co-author, and got accepted by RSC Medicinal Chemistry journal on December 6, 2024. Please click below to visit the RSC Medicinal Chemistry journal for more details:>

Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumorsMelanoma, the most fatal form of skin cancer, often becomes resistant to the current therapeutic approaches in most patients. To explore new treatment options, fused thiazole derivatives were synthesized, and several of these compounds demonstrated potent anti-melanoma activity both in vitro and in vivo. These comp

It is thrilling to announce that SIAM CHOWDHURY attended his 5th conference, The Arkansas IDeA Network of Biomedical Research Excellence (INBRE 2024), on November 8th and 9th, 2024. at the University of Arkansas , Fayetteville, Arkansas

INBRE 2023 was his 3rd number of attending conference. Idea Network of Biomedical Research Excellence (Arkansas INBRE) held on November 3rd & 4th, 2023 at University of Arkansas, Fayetteville, Arkansas. INBRE is one of the biggest conference of United States and grants are designed to enhance biomedical research capacity, expand and strengthen the research capabilities of biomedical faculty and provide access to biomedical resources for promising undergraduate and graduate students.